ClinConnect ClinConnect Logo
Search / Trial NCT05243056

A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Feb 7, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called Y-AMBIENT, is focused on helping young African American women who are dealing with stage I-III breast cancer. The goal is to improve their quality of life through a special program that lasts for four months. Participants will take part in educational sessions over the phone, receive helpful written materials, and watch videos that provide support and information on managing daily life while undergoing cancer treatment.

To be eligible for this study, participants must be women aged 18 to 44 who identify as African American and are currently receiving treatment for breast cancer. They also need to speak English and have access to a phone and the internet. This trial is a great opportunity for young women facing breast cancer to gain valuable resources and support to help them through their treatment journey.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Biologically born women
  • Self-identify as AA
  • Are aged 18 to 44 years on study entry
  • Are diagnosed with breast cancer stage I-III
  • Are in treatment with chemotherapy and/or radiation for stage I-III breast cancer at study entry
  • Are English- speaking
  • Have telephone and internet access
  • Exclusion Criteria:
  • Participation in formal survivorship navigation programs because they are associated with improved health- related outcomes, which could be a confounder

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Columbus, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Timiya Nolan, PhD

Principal Investigator

Ohio State University Comprehensive Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials